Mr. Eli Lilly (grandson of the company founder, Colonel Eli Lilly)
"Research is the heart of the business, the soul of the enterprise."
For scientists, by scientists.
Making lives better together.
The Lilly Open Innovation Drug Discovery (OIDD) Program is founded on the belief that pharmaceutical companies, research institutions and academia share a mutual desire to advance innovative biomedical science. OIDD is a premier collaborative platform that unites global investigators with Lilly scientists to both uncover and create innovation that may positively impact the people we serve.